These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

714 related articles for article (PubMed ID: 24290832)

  • 41. A novel link between G6PD deficiency and hemolysis in patients with continuous-flow left ventricular assist devices.
    Alhosaini H; Jensen BC; Chang PP; Sheridan BC; Katz JN
    J Heart Lung Transplant; 2014 Jan; 33(1):116-7. PubMed ID: 24290168
    [No Abstract]   [Full Text] [Related]  

  • 42. Single-Center Experience With HeartMate II Left Ventricular Assist Device Explantation.
    Tchantchaleishvili V; Cheyne C; Sherazi S; Melvin AL; Hallinan W; Chen L; Todd Massey H
    Artif Organs; 2016 Dec; 40(12):1145-1149. PubMed ID: 27076358
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Role of echocardiography in patients with intravascular hemolysis due to suspected continuous-flow LVAD thrombosis.
    Fine NM; Topilsky Y; Oh JK; Hasin T; Kushwaha SS; Daly RC; Joyce LD; Stulak JM; Pereira NL; Boilson BA; Clavell AL; Edwards BS; Park SJ
    JACC Cardiovasc Imaging; 2013 Nov; 6(11):1129-40. PubMed ID: 24094831
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Surgical approach to continuous-flow left ventricular assist device explantation: A comparison of outcomes.
    Baldwin AC; Sandoval E; Letsou GV; Mallidi HR; Cohn WE; Frazier OH
    J Thorac Cardiovasc Surg; 2016 Jan; 151(1):192-8. PubMed ID: 26344685
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support).
    Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD
    J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Hematologic markers better predict left ventricular assist device thrombosis than echocardiographic or pump parameters.
    Bartoli CR; Ghotra AS; Pachika AR; Birks EJ; McCants KC
    Thorac Cardiovasc Surg; 2014 Aug; 62(5):414-8. PubMed ID: 24995532
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Right heart dysfunction after left ventricular assist device implantation: a comparison of the pulsatile HeartMate I and axial-flow HeartMate II devices.
    Patel ND; Weiss ES; Schaffer J; Ullrich SL; Rivard DC; Shah AS; Russell SD; Conte JV
    Ann Thorac Surg; 2008 Sep; 86(3):832-40; discussion 832-40. PubMed ID: 18721570
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastrointestinal bleeding with the HeartMate II left ventricular assist device.
    Morgan JA; Paone G; Nemeh HW; Henry SE; Patel R; Vavra J; Williams CT; Lanfear DE; Tita C; Brewer RJ
    J Heart Lung Transplant; 2012 Jul; 31(7):715-8. PubMed ID: 22425231
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Coagulopathy in Mechanical Circulatory Support: A Fine Balance.
    Rosenthal JL; Starling RC
    Curr Cardiol Rep; 2015 Dec; 17(12):114. PubMed ID: 26482757
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Role of computed tomography angiography for HeartMate II left ventricular assist device thrombosis.
    Yu SN; Han J; Takeda K; Ginns JN; Kurlansky PA; Garan AR; Yuzefpolskaya M; Topkara VK; Colombo PC; Naka Y; Takayama H
    Int J Artif Organs; 2018 Jun; 41(6):325-332. PubMed ID: 29562790
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Surgical technique influences HeartMate II left ventricular assist device thrombosis.
    Taghavi S; Ward C; Jayarajan SN; Gaughan J; Wilson LM; Mangi AA
    Ann Thorac Surg; 2013 Oct; 96(4):1259-1265. PubMed ID: 23968757
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Dynamic prediction of left ventricular assist device pump thrombosis based on lactate dehydrogenase trends.
    Hurst TE; Xanthopoulos A; Ehrlinger J; Rajeswaran J; Pande A; Thuita L; Smedira NG; Moazami N; Blackstone EH; Starling RC
    ESC Heart Fail; 2019 Oct; 6(5):1005-1014. PubMed ID: 31318170
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Natural history and clinical effect of aortic valve regurgitation after left ventricular assist device implantation.
    Rajagopal K; Daneshmand MA; Patel CB; Ganapathi AM; Schechter MA; Rogers JG; Milano CA
    J Thorac Cardiovasc Surg; 2013 May; 145(5):1373-9. PubMed ID: 23312101
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Safety of discontinuation of anti-coagulation in patients with continuous-flow left ventricular assist devices.
    Kamdar F; Eckman P; John R
    J Heart Lung Transplant; 2014 Mar; 33(3):316-8. PubMed ID: 24462558
    [No Abstract]   [Full Text] [Related]  

  • 55. Early intervention for lactate dehydrogenase elevation improves clinical outcomes in patients with the HeartMate II left ventricular assist device: Insights from the PREVENT study.
    Thenappan T; Stulak JM; Agarwal R; Maltais S; Shah P; Eckman P; Emani S; Katz JN; Gregoric I; Keebler ME; Uriel N; Adler E; Chuang J; Farrar DJ; Sundareswaran KS; John R
    J Heart Lung Transplant; 2018 Jan; 37(1):25-32. PubMed ID: 29153636
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Early Detection of Pump Thrombosis in Patients With Left Ventricular Assist Device.
    Grabska J; Schlöglhofer T; Gross C; Maw M; Dimitrov K; Wiedemann D; Zimpfer D; Schima H; Moscato F
    ASAIO J; 2020 Apr; 66(4):348-354. PubMed ID: 31294721
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Effects of pulsatile- and continuous-flow left ventricular assist devices on left ventricular unloading.
    Garcia S; Kandar F; Boyle A; Colvin-Adams M; Lliao K; Joyce L; John R
    J Heart Lung Transplant; 2008 Mar; 27(3):261-7. PubMed ID: 18342746
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Infectious complications in patients with left ventricular assist device: etiology and outcomes in the continuous-flow era.
    Topkara VK; Kondareddy S; Malik F; Wang IW; Mann DL; Ewald GA; Moazami N
    Ann Thorac Surg; 2010 Oct; 90(4):1270-7. PubMed ID: 20868826
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Correlation of Pre-Explant Lactate Dehydrogenase Concentrations and Findings During Post-Explant Pump Analysis of the HeartMate II Left Ventricular Assist Device.
    Sood V; Alam O; Tchantchaleishvili V; Pagani FD; Aaronson KD; Haft J; Joyce DL; Joyce LD; Daly RC; Maltais S; Stulak JM
    Ann Thorac Surg; 2017 Apr; 103(4):1207-1213. PubMed ID: 27743635
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Watchful Waiting in Continuous-Flow Left Ventricular Assist Device Patients With Ongoing Hemolysis Is Associated With an Increased Risk for Cerebrovascular Accident or Death.
    Levin AP; Saeed O; Willey JZ; Levin CJ; Fried JA; Patel SR; Sims DB; Nguyen JD; Shin JJ; Topkara VK; Colombo PC; Goldstein DJ; Naka Y; Takayama H; Uriel N; Jorde UP
    Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27166248
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 36.